Bill of Health

OCTOBER 11, 2023

Medical Product Industry Ties to Patient Advocacy Organizations’ Executive Leadership. Changes in the Number of Continuation Patents on Drugs Approved by the FDA. The Regulatory Repercussions of Approving Muscular Dystrophy Medications on the Basis of Limited Evidence. Ann Intern Med. 2023 Aug 22. Epub ahead of print.

Patient Advocacy 144

Patient Advocacy Medicare Medicare FDA 144

HIT Consultant

MAY 2, 2022

The FDA is attempting to address this, having issued guidelines related to diversity in clinical trials in November 2020 – perhaps prompted by widespread media coverage of the fact that the black members of the society and other people of color were underrepresented in clinical trials for COVID-19 vaccines.

COVID-19 Vaccine 97

COVID-19 Vaccine Patient Advocacy Pharmaceutical Industry COVID-19 97

Jane Sarashon

MAY 22, 2023

This coalition of patient advocacy organizations includes AIDS United, the Allergy & Asthma Network, the American Kidney Fund, Autism Speaks, Black Women’s Health Imperative, the Crohn’s & Colitis Foundation, the Global Liver Institute, National Consumers’ League, and many other patient-driven coalitions. .”

Patient Advocacy 52

Patient Advocacy FDA Hospitals Doctors 52

Health Populi

JANUARY 7, 2019

This week’s heart-and-food tech announcements at #CES2019 coincide with an FDA recall on a popular drug prescribed to treat hypertension (high blood pressure). In this category, I point to PEAR Therapeutics , which has a portfolio of FDA-cleared digital therapeutics (DTx) offerings. Limiting alcohol consumption.

FDA 67

FDA Patient Advocacy Medicare Medicare 67

HIT Consultant

FEBRUARY 22, 2023

Andrew Barnhill, Head of Public Policy, Global Legal, IQVIA Alexandra Weiss, Director of Strategic Partnerships, Patient Advocacy Organizations, IQVIA Diversity is paramount to the success of clinical research, both ethically and scientifically.

Patient Advocacy 98

Patient Advocacy Health Insurance FDA Governance 98

The Digital Health Corner

NOVEMBER 28, 2016

Digital health technology has seen an incredible growth in the last few years, fueled by a combination of consumerization of wearable technologies, ubiquity of mobile devices, proliferation of technology incubators, attention by government health and regulatory agencies and involvement of large companies heretofore not focused on healthcare.

Public Health 68

Public Health Health Services Administration Patient Advocacy Governance 68

Health Law Advisor

JULY 21, 2023

Food and Drug Administration (FDA) as breakthrough devices. [1] 5] However, devices in earlier stages of the FDA approval process often lack the clinical evidence needed to satisfy the “reasonable and necessary” criteria to justify CMS’s establishment of a national coverage standard.

FDA 52

FDA Medicare Medicare Patient Advocacy 52